We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
BP
BP
$113B
| $225K | ﹤0.01% |
6,371
-369
| -5% | -$13.7K |
|
627
iShares Floating Rate Bond ETF
FLOT
$10.1B
| $223K | ﹤0.01% |
4,395
| – | – |
|
628
Invesco Variable Rate Preferred ETF
VRP
$2.99B
| $223K | ﹤0.01% |
10,000
| – | – |
|
629
International Paper
IP
$22.3B
| $221K | ﹤0.01% |
6,951
-88
| -1% | -$2.88K |
|
630
Cable One
CABO
$213M
| $220K | ﹤0.01% |
335
-680
| -67% | -$459K |
|
631
Archer Daniels Midland
ADM
$41.4B
| $219K | ﹤0.01% |
2,904
-500
| -15% | -$37.9K |
|
632
Camden National
CAC
$924M
| $218K | ﹤0.01% |
7,050
| – | – |
|
|
BFS
633
Saul Centers
BFS
$875M
| $217K | ﹤0.01% |
5,900
-200
| -3% | -$7.19K |
|
634
Mativ Holdings
MATV
$448M
| $217K | ﹤0.01% |
+14,321
| New | +$253K |
|
635
Post Holdings
POST
$4.12B
| $215K | ﹤0.01% |
2,481
| – | – |
|
636
Elevance Health
ELV
$81.9B
| $215K | ﹤0.01% |
483
-9
| -2% | -$4.15K |
|
637
Urban Edge Properties
UE
$2.94B
| $215K | ﹤0.01% |
13,902
| – | – |
|
638
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $213K | ﹤0.01% |
4,246
| – | – |
|
639
Dominion Energy
D
$62.5B
| $212K | ﹤0.01% |
4,102
| – | – |
|
640
DexCom
DXCM
$27.6B
| $212K | ﹤0.01% |
1,647
+107
| +7% | +$12.9K |
|
641
Ford
F
$57.3B
| $211K | ﹤0.01% |
13,966
+57
| +0.4% | +$721 |
|
642
FS Bancorp
FSBW
$324M
| $210K | ﹤0.01% |
7,000
| – | – |
|
643
Mattel
MAT
$4.17B
| $209K | ﹤0.01% |
10,710
-8,250
| -44% | -$149K |
|
|
FL
644
DELISTED
Foot Locker
FL
| $208K | ﹤0.01% |
7,681
+7,400
| +2,633% | +$252K |
|
645
Concentrix
CNXC
$1.36B
| $206K | ﹤0.01% |
2,550
| – | – |
|
646
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $206K | ﹤0.01% |
2,000
| – | – |
|
647
Murphy USA
MUSA
$11.3B
| $205K | ﹤0.01% |
660
| – | – |
|
648
MarketAxess Holdings
MKTX
$4.15B
| $205K | ﹤0.01% |
785
| – | – |
|
649
West Pharmaceutical
WST
$23.1B
| $202K | ﹤0.01% |
529
| – | – |
|
650
MVB Financial
MVBF
$374M
| $200K | ﹤0.01% |
9,500
| – | – |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.